Shu Uin Gan

1.3k citations
44 papers · 980 indexed · h-index 18

Impact in

Papers in

    • Mesenchymal stem cell research 9
    • Virus-based gene therapy research 8
    • Wound Healing and Treatments 4

Shu Uin Gan

42 papers receiving 967 citations

Peers

Shu Uin Gan
Comparison fields: 5 of 84
  • Genetics 271
  • Rehabilitation 92
  • Immunology 182
  • Surgery 306
  • Biomaterials 86
Replace Richard J. Bauer with:
Richard J. Bauer Germany
Martine Dunnwald United States
Virginia Egea Germany
Qilin Huang China
Zhengzhao Liu China
Weimin Deng China
Yingjun Su China
Nikola Arsic France
Qingwang Han China
Jason S. Rockel Canada
Shu Uin Gan relative to Richard J. Bauer Germany Richard J. Bauer's profile →
Citations per field
00.5×1.5×
Richard J. Bauer · 1×
Citations per year

Countries citing papers authored by Shu Uin Gan

Since Specialization
Citations

This map shows the geographic impact of Shu Uin Gan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu Uin Gan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu Uin Gan more than expected).

Fields of papers citing papers by Shu Uin Gan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shu Uin Gan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu Uin Gan. The network helps show where Shu Uin Gan may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Shu Uin Gan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Shu Uin Gan Line = papers co-authored together Shu Uin Gan links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20241
2 20240
3 20213
4 202015
5 202016
6 20188
7 20131
8 201370
9 201318
10 201322
11 201322
12 201275
13 201212
14 201275
15 20129
16 201126
17 201036
18 201027
19 200059
20 199970

About Shu Uin Gan

Shu Uin Gan is a scholar working on Genetics, Rehabilitation, Genetics, Surgery and Dermatology, having authored 44 papers that have together received 980 indexed citations. Recurring topics across this work include Pancreatic function and diabetes (11 papers), Mesenchymal stem cell research (9 papers), Virus-based gene therapy research (8 papers), Tissue Engineering and Regenerative Medicine (7 papers), Pluripotent Stem Cells Research (6 papers), RNA Interference and Gene Delivery (4 papers), Wound Healing and Treatments (4 papers) and Immune Cell Function and Interaction (4 papers). The work is most often cited by research in Genetics (271 citations), Rehabilitation (92 citations), Immunology (182 citations), Surgery (306 citations) and Biomaterials (86 citations). Shu Uin Gan has collaborated with scholars based in Singapore, United Kingdom and United States. Frequent co-authors include Roy Calne, Kok‐Onn Lee, Ariff Bongso, Arijit Biswas, Mahesh Choolani, Kalamegam Gauthaman, Joop Gäken, Farzin Farzaneh, Arjunan Subramanian and Cheryl L. Chernicky. Their work appears in journals such as Cell Transplantation, Journal of Cellular Biochemistry, Stem Cell Research, Gene Therapy and The Journal of Gene Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026